Skip to content

Head to head

FlexSure vs Venus Versa (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview
Purchase cost
Catalog new-price ranges: FlexSure, $40k–$70k; Venus Versa, $70k–$110k. Check the source notes and request current quotes.
Practice fit
Both are listed under body contouring. Check each model’s US regulatory status and labeled indications for your intended use.

Body Contouring

View full device profile →

Body Contouring

View full device profile →

Price comparison

New price range

Cynosure FlexSure
$40k–$70kSource not documented
Venus Versa
$70k–$110kSource not documented

Used asking range

Cynosure FlexSure
Not published
Venus Versa
$20k–$45kSource not documented

Payback calculator

Cynosure FlexSure
View ROI calculator

Next step

Cynosure FlexSure
Venus Versa

Consumable economics

Consumable cost / lock-in

Cynosure FlexSure
Venus Versa
Supply pricing is not documented with a dated source yet. Request an itemized supply quote. — soft-lock (defeatable) — internal shot-count chip, resettable by third-party refurbishers

Service cost

Cynosure FlexSure
Not published
Venus Versa
Not published

FDA clearance

FDA status & indication

Cynosure FlexSure
FDA ClearedK200241
Read FDA indication wording
The TempSure™ System has the following indications for use: The 10mm, 15mm, and 20mm Smart Handpieces are indicated for non-ablative treatment of mild to moderate facial wrinkles and rhytids. The 18mm, 25mm, 30mm, 60mm Smart Handpieces and FlexSure™ applicators provide heating for the purpose of elevating tissue temperature for selected medical conditions such as temporary relief of pain, muscle spasms, and increase in local circulation. The massage device is intended to provide a temporary reduction in the appearance of cellulite. The following surgical modes are applicable to the generator: Coagulation/Hemostasis: General surgical procedures including urologic, thoracic, plastic, reconstructive, and gynecological procedures where electrosurgical coagulation of tissue is performed. Cutting: snoring, submucosal palatal shrinkage, traditional uvulopalatoplasty (RAUP), myringotomy with effective hemorrhage control, epistaxis treatment, turbinate shrinkage, skin incisions, biopsy, cysts, abscesses, tumors, cosmetic repairs, development of skin flaps, skin tags and blepharoplasty. Blended Cutting and Coagulation: snoring, submucosal palatal shrinkage, traditional uvulopalatoplasty (RAUP), myringotomy with effective hemorrhage control, epistaxis treatment, turbinate shrinkage, skin tags, papilloma keloids, keratosis, verrucae, basal cell carcinoma, nevi, fistulas, epithelioma, cosmetic repairs, cysts, abscesses, and development of skin flaps. Fulguration: basal cell carcinoma, papilloma, cyst destruction, tumors, verrucae, hemostasis. Bipolar: pinpoint precise coagulation, pinpoint hemostasis in any field (wet or dry), snoring, submucosal palatal shrinkage, traditional uvulopalatoplasty (RAUP), myringotomy with effective hemorrhage control, epistaxis treatment and turbinate shrinkage.
Venus Versa
FDA ClearedK153717
Read FDA indication wording
The Venus Versa System is a multi-application device intended to be used in aesthetic and cosmetic procedures. The SR515 and SR580 IPL applicators are indicated for the following: • Treatment of benign pigmented epidermal and cutaneous lesions including: hyperpigmentation, melasma, ephelides (freckles), lentigines, nevi, and cafe-au-lait macules. • Treatment of benign cutaneous vascular lesions including port wine stains, hemangiomas, facial, truncal and leg telangiectasias, rosacea, angiomas and spider angiomas, poikiloderma of civatte, leg veins and venous malformations. The HR650, HR690, HR650XL, and HR690XL IPL applicators are indicated for the removal of unwanted hair and to effect stable long-term or permanent hair reduction for skin types I-IV. Permanent hair reduction is defined as the longterm stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regimen. The Venus Concept ACDUAL applicator is intended to be used for the treatment of acne vulgaris. The Diamondpolar and Octipolar applicators are non-invasive devices intended for use in dermatologic and general surgery procedures for females for the non-invasive treatment of moderate to severe facial wrinkles and rhytides in Fitzpatrick skin types I-IV. The Viva applicator is intended for dermatological procedures requiring ablation and resurfacing of the skin.

Which chains run each

Chain adoption

Cynosure FlexSure
0 recorded pairings
Venus Versa
1 recorded pairing

Chains using it

Cynosure FlexSure
Venus Versa
  • Formula Wellness(Confirmed)

Approved reviews

Cynosure FlexSure
0
Venus Versa
0

Specs and platform

Manufacturer

Cynosure FlexSure
Cynosure
Venus Versa
Venus Concept

Built by (OEM)

Cynosure FlexSure
Cynosure LLC
Venus Versa
Venus Concept Inc.

Category

Cynosure FlexSure
Body Contouring
Venus Versa
Body Contouring

Technology

Cynosure FlexSure
Wrap-around hands-free RF applicators
Venus Versa
Multi-application platform w/ body RF (IPL)

Launch year

Cynosure FlexSure
2021
Venus Versa
2016

Status

Cynosure FlexSure
Current
Venus Versa
Current

Manufacturer source record

Cynosure FlexSure
No linked source on file.
Venus Versa
No linked source on file.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.